ℹ️
🇬🇧
Search
Search for people relevant for "HLA B-27"
HLA B-27
Person
Class
Person
Publication
Programmes
MUDr. Heřman Mann Ph.D.
Academic staff at First Faculty of Medicine
143 publications
Publications
publication
New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis
2023 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study
2023 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Cardiovascular risk in myositis patients compared with the general population
2023 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study
2023 |
First Faculty of Medicine
publication
Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome
2023 |
First Faculty of Medicine
publication
Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies
2023 |
First Faculty of Medicine
publication
Hsp90 Levels in Idiopathic Inflammatory Myopathies and Their Association With Muscle Involvement and Disease Activity: A Cross-Sectional and Longitudinal Study
2022 |
First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
publication
Hsp90 as a Myokine: Its Association with Systemic Inflammation after Exercise Interventions in Patients with Myositis and Healthy Subjects
2022 |
First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
publication
Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study
2022 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Real-world Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients with Psoriatic Arthritis in Thirteen European Countries
2022 |
First Faculty of Medicine
Load more publications (133)
Loading network view...